<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03360656</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00074620</org_study_id>
    <nct_id>NCT03360656</nct_id>
  </id_info>
  <brief_title>Transnasal Induction of Normothermia in Febrile Stroke Patients</brief_title>
  <official_title>Transnasal Induction of Normothermia in Febrile Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CoolTech LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CoolTech LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal&#xD;
      Thermal Regulating Device in reducing temperature in a population of febrile subjects who&#xD;
      meet the inclusion/exclusion criteria.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Temperature reduction</measure>
    <time_frame>8 - 24 hours</time_frame>
    <description>Ability of transnasal thermal regulating device to reduce core body temperature</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Hemorrhagic</condition>
  <condition>Fever</condition>
  <condition>Seizures</condition>
  <condition>Metabolic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>Transnasal Thermal Regulating Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consented subjects will undergo cooling via transnasal thermal regulating device for a period of 8 to 24 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transnasal Thermal Regulating Device</intervention_name>
    <description>Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours</description>
    <arm_group_label>Transnasal Thermal Regulating Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Admitted to the Neurosciences Critical Care Unit (NCCU).&#xD;
&#xD;
          2. Patient has ischemic or hemorrhagic stroke, seizure, or metabolic encephalopathy.&#xD;
&#xD;
          3. Patient is orally intubated or has tracheostomy tube and is mechanically ventilated.&#xD;
&#xD;
          4. Planned stay in NCCU &gt; 24 hours.&#xD;
&#xD;
          5. Must have informed consent from the patient or the legally authorized representative&#xD;
             (LAR)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age &lt; 18 years old or &gt; 95 years.&#xD;
&#xD;
          2. Intubation is contraindicated.&#xD;
&#xD;
          3. With a coagulopathy. INR above 1.5 or PTT above 45 seconds.&#xD;
&#xD;
          4. Hemodynamic instability, including elevated SPB for &gt;5 minutes despite standard of&#xD;
             care interventions (SPB ≥ 160 mmHg for intracerebral hemorrhagic stroke; SPB ≥ 220&#xD;
             mmHg for subarachnoid hemorrhagic stroke or ischemic stroke).&#xD;
&#xD;
          5. History of cryoglobulinemia.&#xD;
&#xD;
          6. History of sickle cell disease.&#xD;
&#xD;
          7. History of serum cold agglutinin disease.&#xD;
&#xD;
          8. Active/ongoing of nose bleeds.&#xD;
&#xD;
          9. Known or suspected pregnancy.&#xD;
&#xD;
         10. Participation in another ongoing investigational study.&#xD;
&#xD;
         11. Prisoners and/or patients for whom no LAR is available.&#xD;
&#xD;
         12. Patient is in airborne/droplet disease isolation protocol.&#xD;
&#xD;
         13. Patient is or suspected to be immunocompromised;&#xD;
&#xD;
         14. Low platelet count defined as &lt; 100k (thrombocytopenia).&#xD;
&#xD;
         15. Nasal septal deviations (per CT scan; any degree).&#xD;
&#xD;
         16. Chronic rhinosinusitis.&#xD;
&#xD;
         17. Prior skull-based surgery&#xD;
&#xD;
         18. Penetrating cranial trauma.&#xD;
&#xD;
         19. Recent nasal trauma or anterior base skull fracture.&#xD;
&#xD;
         20. Presence of cardiac arrhythmias including: sustained tachycardia defined as heart rate&#xD;
             above 120 beats per minute, or sustained bradycardia defined as heart rate below 60&#xD;
             beats per minute.&#xD;
&#xD;
         21. Refractory hypoxemia defined as partial pressure of oxygen in arterial blood (paO2)&#xD;
             below 60 torr or oxyhemoglobin saturation below 90% despite endotracheal intubation,&#xD;
             mechanical ventilation, and provision of supplemental oxygen of up to 0.60.&#xD;
&#xD;
         22. Refractory hypercarbia defined as partial pressure of carbon dioxide in arterial blood&#xD;
             (paCO2) above 50 torr despite endotracheal intubation and conventional mechanical&#xD;
             ventilation.&#xD;
&#xD;
         23. History of cardiac arrhythmia as listed above.&#xD;
&#xD;
         24. BMI of ≤ 15 kg/m2 or ≥ 40kg/m2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neeraj Badjatia, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ of Maryland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neeraj Badjatia, MD MS</last_name>
    <phone>4103284515</phone>
    <email>nbadjatia@umm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Casey Hannan, BS</last_name>
    <phone>410.646.8522</phone>
    <email>channan@cooltechcorp.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neeraj Badjatia, MD MS</last_name>
      <phone>410-328-4515</phone>
      <email>nbadjatia@umm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth White, RN</last_name>
      <phone>443-287-5837</phone>
      <email>ewhite11@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Parish, RN</last_name>
      <phone>410.614.0891</phone>
      <email>maparish@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Landmesser, BS</last_name>
      <phone>215-503-5646</phone>
      <email>matthew.landmesser@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jaimie Dougherty, BS</last_name>
      <phone>215-955-7962</phone>
      <email>Jaime.Dougherty@jefferson.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Texas, Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H Choi, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 28, 2017</study_first_submitted>
  <study_first_submitted_qc>December 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2017</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, College Park</investigator_affiliation>
    <investigator_full_name>Neeraj Badjatia</investigator_full_name>
    <investigator_title>Professor, Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>shivering, fever, normothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
    <mesh_term>Brain Diseases, Metabolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

